SARS-CoV-2 variants, vaccines, and host immunity

P Mistry, F Barmania, J Mellet, K Peta… - Frontiers in …, 2022 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new beta coronavirus
that emerged at the end of 2019 in the Hubei province of China. SARS-CoV-2 causes …

COVID-19 transmission, current treatment, and future therapeutic strategies

VS Salian, JA Wright, PT Vedell, S Nair… - Molecular …, 2021 - ACS Publications
At the stroke of the New Year 2020, COVID-19, a zoonotic disease that would turn into a
global pandemic, was identified in the Chinese city of Wuhan. Although unique in its …

COVID-19 vaccine hesitancy and related fears and anxiety

A Bendau, J Plag, MB Petzold, A Ströhle - International …, 2021 - Elsevier
Background Vaccination is crucial to limit the pandemic spread of SARS-CoV-2/COVID-19.
Therefore, besides the development and supply of vaccines, it is essential that sufficient …

COVID-19 vaccines: The status and perspectives in delivery points of view

JY Chung, MN Thone, YJ Kwon - Advanced drug delivery reviews, 2021 - Elsevier
Due to the high prevalence and long incubation periods often without symptoms, the severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected millions of individuals …

[HTML][HTML] COVID-19 vaccines: Current status and implication for use in Indonesia

Y Ophinni, AS Hasibuan, A Widhani… - Acta Medica …, 2020 - actamedindones.org
Abstract The coronavirus disease 2019 (COVID-19) has inflicted catastrophic damages in
public health, economic and social stability—putting life globally on hold in 2020 and …

Why and how vaccines work

A Iwasaki, SB Omer - Cell, 2020 - cell.com
Why and How Vaccines Work: Cell Skip to Main Content Advertisement Cell This journal offers
authors two options (open access or subscription) to publish research Submit Log in Register …

Efforts at COVID-19 vaccine development: challenges and successes

A Haque, AB Pant - Vaccines, 2020 - mdpi.com
The rapid spread of SARS-CoV-2, the new coronavirus (CoV), throughout the globe poses a
daunting public health emergency. Different preventive efforts have been undertaken in …

[HTML][HTML] Thyroid as a target of adjuvant autoimmunity/inflammatory syndrome due to mRNA-based SARS-CoV2 vaccination: from Graves' disease to silent thyroiditis

A Pujol, LA Gómez, C Gallegos, J Nicolau… - Journal of …, 2022 - Springer
Background As COVID-19 became a pandemic, the urgent need to find an effective
treatment vaccine has been a major objective. Vaccines contain adjuvants which are not …

Advances in gene-based vaccine platforms to address the COVID-19 pandemic

D Pushparajah, S Jimenez, S Wong, H Alattas… - Advanced drug delivery …, 2021 - Elsevier
The novel betacoronavirus, SARS-CoV-2 (severe acute respiratory syndrome coronavirus
2), has spread across the globe at an unprecedented rate since its first emergence in Wuhan …

Progress and pitfalls in the quest for effective SARS-CoV-2 (COVID-19) vaccines

KL Flanagan, E Best, NW Crawford, M Giles… - Frontiers in …, 2020 - frontiersin.org
There are currently around 200 SARS-CoV-2 candidate vaccines in preclinical and clinical
trials throughout the world. The various candidates employ a range of vaccine strategies …